Literature DB >> 16949923

Cellular and reticular variants of hemangioblastoma differ in their cytogenetic profiles.

Christian H Rickert1, Martin Hasselblatt, Astrid Jeibmann, Werner Paulus.   

Abstract

Capillary hemangioblastomas of the central nervous system are benign tumors and occur either sporadically or as a manifestation of von Hippel-Lindau disease. A rarer cellular and a more common reticular variant can be distinguished on the basis of the abundance of the stromal cell component, with the cellular variant being significantly associated with a greater probability of recurrence. To investigate whether these subtypes differ in their cytogenetic profile, a comparative genomic hybridization analysis of 10 cellular and 10 reticular hemangioblastomas was undertaken. Comparative genomic hybridization revealed DNA copy number changes in 14 of 20 cases (8 of 10 cellular and 6 of 10 reticular hemangioblastomas). The most common changes overall were losses of chromosomes 19 (35%), 6 (30%), and 22q (15%), whereas loss of 3 and gain of 4 were encountered in one case each (5%). The cellular variant showed losses of chromosomes 6 (60%), 22q and 19 (20% each), as well as gain of 4 (10%), whereas the reticular variant presented with losses of chromosomes 19 (50%), 22q and 3 (10% each). Loss of chromosome 6 was significantly associated with the cellular subtype (P < .005), whereas loss of 19/19p was found more frequently in the reticular variant, albeit not significantly (P = .16). In conclusion, our data may point toward different genetic pathways in the pathogenesis of the 2 histologic subtypes of capillary hemangioblastoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949923     DOI: 10.1016/j.humpath.2006.05.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.

Authors:  Steven A Mills; Michael C Oh; Martin J Rutkowski; Michael E Sughrue; Igor J Barani; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

Review 2.  Supratentorial hemangioblastomas: three case reports and review of the literature.

Authors:  D J She; Z Xing; Y Liu; D R Cao
Journal:  Clin Neuroradiol       Date:  2012-12-04       Impact factor: 3.649

Review 3.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

4.  Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease.

Authors:  S B Shively; S Beltaifa; B Gehrs; H Duong; J Smith; N A Edwards; Rr Lonser; M Raffeld; A O Vortmeyer
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

Review 5.  Sporadic haemangioblastoma of the kidney with rhabdoid features and focal CD10 expression: report of a case and literature review.

Authors:  Wei-hua Yin; Jian Li; John K C Chan
Journal:  Diagn Pathol       Date:  2012-04-12       Impact factor: 2.644

Review 6.  Supratentorial haemangioblastoma without von Hippel-Lindau syndrome in an adult: A rare tumor with review of literature.

Authors:  Sharad Pandey; Vivek Sharma; Deepa Pandey; Vikul Kumar; Mohan Kumar
Journal:  Asian J Neurosurg       Date:  2016 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.